South Korea Left Ventricular Assist Device Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Implantable LVAD, Transcutaneous LVAD), By Application (Bridge-to-Transplant (BTT), Destination Therapy (DT), Bridge-to-Recovery (BTR), Bridge-to-Candidacy (BTC)), and South Korea Left Ventricular Assist Device Market Insights, Industry Trend, Forecasts to 2035

South Korea Left Ventricular Assist Device Market Insights Forecasts to 2035

• The South Korea Left Ventricular Assist Device Market Size is Expected to Grow at a CAGR of around 6.3% from 2025 to 2035
• The South Korea Left Ventricular Assist Device Market Size is Expected to hold a significant Share by 2035

According to a research report published by Spherical Insights & Consulting, The South Korea Left Ventricular Assist Device Market Size is anticipated to grow at a CAGR of 6.3% from 2025 to 2035. The market is driven by the growing prevalence of advanced heart failure, limited donor heart availability, and technological advancements in centrifugal-flow pumps alongside structured LVAD programs that improve patient outcomes.

Market Overview

South Korea left the ventricular assist device market refers to the section of the mechanical circulatory support system designed to help left ventricle to pump blood for patients with advanced heart failure. In South Korea, the market is expanding due to severe heart failure, an aging population and limited availability of donor hearts, which increases the demand for LVADs in the form of Bridge-to-Transplant, Bridge-to-Kandidesi or Destination Therapy. Technological progresses such as magnetically levitated centrifugal pumps, compact implantable designs, and better hemochapatability have increased the results of the patient and reduced complications. The presence of special cardiac centers, better reimbursement routes, and structured multi -woller LVAD programs support wide adoption. Additionally, raising awareness among cardiologists and improving post-implant care infrastructure is promoting continuous growth in the South Korean LVAD market.

Report Coverage

This research report categorizes the market for the South Korea left ventricular assist device market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the South Korea left ventricular assist device market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the South Korea left ventricular assist device market.

Driving Factors

South Korea left ventricular assist device market is driven by advanced heart failure, an aging population and lack of donor hearts, increasing dependence on LVADs for bridge-to-transplant and destination therapy. Progress in centrifugal-flow pump technology, improvement in hemochapatability, and expansion of special LVAD programs further enhanced the adoption rates of the adoption and the patient's survival rates.

Restraining Factors

South Korea left ventricular assist device market is restrained by high device and lifetime management costs, bleeding risk, stroke and driveline infection, limited special transplantation centers and intensive follow -up requirements, which can obstruct patient eligibility and wide adoption.

Market Segmentation

The South Korea left ventricular assist device market share is classified into product type and application.

• The implantable LVAD segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea left ventricular assist device market is segmented by product type into implantable LVAD and transcutaneous LVAD. Among these, the implantable LVAD segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period. The reason for this is that implantable LVADs improve the risk of better patient dynamics, infection, and increase comfort compared to the transcutaneous system, making them a preferred option for long-term communication support in both patients with bridge-to-transplant and destination therapy.

• The bridge-to-transplant (BTT) segment dominated the market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea left ventricular assist device market is segmented by application into bridge-to-transplant (BTT), destination therapy (DT), bridge-to-recovery (BTR), and bridge-to-candidacy (BTC). Among these, the bridge-to-transplant (BTT) segment dominated the market share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is mainly due to the lack of hearts in South Korea, in which LVADS is served as an important interim solution to maintain the stability and quality of life until an appropriate donor heart becomes available.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the South Korea left ventricular assist device market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Abbott Laboratories
• Medtronic plc
• Berlin Heart GmbH
• Jarvik Heart Inc.
• Terumo Corporation
• Fresenius Medical Care AG & Co. KGaA
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at South Korea, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the South Korea left ventricular assist device market based on the below-mentioned segments:

South Korea Left Ventricular Assist Device Market, By Product Type

• Implantable LVAD
• Transcutaneous LVAD

South Korea Left Ventricular Assist Device Market, By Application

• Bridge-to-Transplant (BTT)
• Destination Therapy (DT)
• Bridge-to-Recovery (BTR)
• Bridge-to-Candidacy (BTC)